4D Molecular Therapeutics Cash Flow Statement (2020-2026) | FDMT

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-47.53M-26.28M-33.13M-34.23M-47.32M-30.28M-49.29M-51.28M-29.08M-33.07M-39.06M-45.45M-77.95M-50.55M-49.44M-89.89M-85.88M18.02M-94.91M-97.48M
Depreciation and Depletion (Quarter)
0.40M0.40M0.40M0.50M0.50M1.00M1.00M1.10M1.10M1.30M1.20M1.20M1.20M1.20M1.30M1.30M1.30M1.30M1.30M1.30M
Share-based Compensation (Quarter)
3.92M3.73M3.93M4.32M4.52M4.35M4.22M4.97M4.56M5.91M5.97M6.07M6.49M14.53M6.99M4.96M4.52M5.55M4.45M5.88M
Cash from Operations (Quarter)
-15.72M-21.84M-23.55M-19.90M-21.02M-22.21M-27.91M-22.07M-1.17M-24.65M-29.09M-30.24M-29.39M-45.86M-47.76M-43.38M-46.50M28.55M-68.12M-70.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.72M-0.58M-0.47M-0.24M0.23M0.40M0.22M0.15M0.48M0.76M2.33M2.24M1.85M1.27M1.17M1.15M1.15M1.13M0.99M
Amortization of Deferred Charges (Quarter)
0.38M0.38M0.38M0.36M0.36M0.37M0.38M0.35M0.40M0.41M0.42M0.43M0.51M0.69M0.70M0.72M0.74M0.76M0.79M0.81M
Depreciation & Amortization (CF) (Quarter)
0.38M0.39M0.41M0.47M0.52M1.01M1.03M1.08M0.99M1.10M1.17M1.19M1.19M1.10M1.05M1.17M1.26M1.22M1.27M1.28M
Change in Working Capital
Change in Receivables (Quarter)
-0.43M-0.74M-0.05M
Change in Account Payables (Quarter)
0.80M1.66M-1.68M0.23M-1.70M1.51M-0.33M0.95M1.37M-1.09M0.70M-0.79M-0.51M1.46M-0.23M4.55M-1.84M4.30M3.53M-4.06M
Change in Accured Expenses (Quarter)
1.06M0.54M-1.07M0.65M1.08M1.82M-3.40M1.16M3.61M2.00M-2.39M3.17M8.11M-2.37M-2.31M3.11M4.98M2.37M-4.12M6.54M
Other Working Capital Changes (Quarter)
-0.52M5.40M-1.02M-1.64M-1.03M2.46M-0.09M0.56M1.15M-0.22M1.32M1.01M-1.82M1.19M1.07M-1.07M-2.75M3.17M3.99M6.53M
Investing Activities
Capital Expenditures (Quarter)
3.67M5.10M6.41M2.07M-8.03M-0.44M1.01M-0.70M1.91M-1.99M0.71M0.35M1.78M0.95M0.14M0.56M-0.09M4.32M0.67M-0.02M
Change in Acquisitions & Divestments (Quarter)
5.00M12.00M65.72M205.28M-135.19M58.87M55.52M30.39M28.51M14.78M23.57M64.87M65.79M166.66M101.62M32.93M49.18M102.40M87.65M
Cash from Investing Activities (Quarter)
-139.01M-32.29M-54.11M57.47M15.37M-35.78M43.13M49.29M29.98M-6.68M-263.26M-73.54M27.30M7.06M31.95M-13.85M17.78M-128.85M68.89M25.54M
Financing Activities
Other financing activities (Quarter)
0.43M0.88M1.42M-0.76M3.11M
Cash from Financing Activities (Quarter)
1.98M116.14M0.63M-0.05M0.46M2.05M10.99M130.52M10.56M4.76M318.83M17.25M0.57M0.60M0.86M0.12M111.98M11.48M42.34M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
114.30M9.65M9.49M0.00M315.72M-19.64M9.70M21.84M
Additional items
Change in Cash (Quarter)
-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-56.37M-28.60M11.69M12.25M-2.12M
Free Cash Flow (Quarter)
-19.39M-26.93M-29.96M-21.97M-12.99M-21.77M-28.92M-21.36M-3.08M-22.66M-29.80M-30.59M-31.17M-46.81M-47.90M-43.93M-46.41M24.23M-68.12M-69.98M
Net Cash Flow (Quarter)
-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-56.37M-28.60M11.69M12.25M-2.12M